Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

16 April 2026

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

73230 result(s) found, displaying 25551 to 25575

TOPIRAMATE-LUPIN topiramate 100 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 200 mg tablet blister Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 200 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 25 mg tablet blister Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 25 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 50 mg tablet blister Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Velotzi Pty Ltd ATF The Velotzi Unit Trust - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

28 June 2022

Cancellation by sponsor

Requested by Velotzi Pty Ltd ATF The Velotzi Unit Trust
Xcel Medical Solutions Pty Ltd - Connector Cancelled under Section 41GL(d) of the Act

28 June 2022

Cancellation by sponsor

Requested by Xcel Medical Solutions Pty Ltd
ACPIO 15 pioglitazone (as hydrochloride) 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ACPIO 30 pioglitazone (as hydrochloride) 30 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ACPIO 45 pioglitazone (as hydrochloride) 45 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ALCOHOLIC IODINE SOLUTION BP solution bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
Amplitude Australia Pty Ltd - Score inset patella- cementless - Polyethylene patella prosthesis Cancelled under Section 41GL(d) of the Act

27 June 2022

Cancellation by sponsor

Requested by Amplitude Australia Pty Ltd
ANSIC Pty Ltd - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

27 June 2022

Cancellation by sponsor

Requested by ANSIC Pty Ltd
ANSIC Pty Ltd - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

27 June 2022

Cancellation by sponsor

Requested by ANSIC Pty Ltd
ANSIC Pty Ltd - Skin-cleaning wipe, non-sterile Cancelled under Section 41GL(d) of the Act

27 June 2022

Cancellation by sponsor

Requested by ANSIC Pty Ltd
APO- CLOPIDOGREL clopidogrel 75mg (as hydrogen sulfate) tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-ACICLOVIR aciclovir 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-AMIODARONE amiodarone hydrochloride 200 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-AMLODIPINE amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-AMLODIPINE amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 20 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 40 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 80 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Apotex Pty Ltd

Last updated

16 April 2026

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

TOPIRAMATE-LUPIN topiramate 100 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

TOPIRAMATE-LUPIN topiramate 200 mg tablet blister Cancelled under Section 30(1)(c) of the Act

TOPIRAMATE-LUPIN topiramate 200 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

TOPIRAMATE-LUPIN topiramate 25 mg tablet blister Cancelled under Section 30(1)(c) of the Act

TOPIRAMATE-LUPIN topiramate 25 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

TOPIRAMATE-LUPIN topiramate 50 mg tablet blister Cancelled under Section 30(1)(c) of the Act

Velotzi Pty Ltd ATF The Velotzi Unit Trust - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

Xcel Medical Solutions Pty Ltd - Connector Cancelled under Section 41GL(d) of the Act

ACPIO 15 pioglitazone (as hydrochloride) 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ACPIO 30 pioglitazone (as hydrochloride) 30 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ACPIO 45 pioglitazone (as hydrochloride) 45 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ALCOHOLIC IODINE SOLUTION BP solution bottle Cancelled under Section 30(1)(c) of the Act

Amplitude Australia Pty Ltd - Score inset patella- cementless - Polyethylene patella prosthesis Cancelled under Section 41GL(d) of the Act

ANSIC Pty Ltd - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

ANSIC Pty Ltd - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

ANSIC Pty Ltd - Skin-cleaning wipe, non-sterile Cancelled under Section 41GL(d) of the Act

APO- CLOPIDOGREL clopidogrel 75mg (as hydrogen sulfate) tablets blister pack Cancelled under Section 30(1)(c) of the Act

APO-ACICLOVIR aciclovir 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-AMIODARONE amiodarone hydrochloride 200 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

APO-AMLODIPINE amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-AMLODIPINE amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 20 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 40 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 80 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect